Prot #R475-PN-1523: A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients with Pain Due to Osteoarthritis of the Knee or Hip

Project: Research project

Project Details

StatusActive
Effective start/end date5/12/16 → 5/12/27

Funding

  • ICON Clinical Research, LLC ((OE) Prot #R475-PN-1523 // (OE) Prot #R475-PN-1523)
  • Regeneron Pharmaceuticals, Inc. ((OE) Prot #R475-PN-1523 // (OE) Prot #R475-PN-1523)